| Bioactivity | PKI 14-22 amide,myristoylated is a potent cAMP-dependent PKA inhibitor. PKI 14-22 amide,myristoylated reduces the IgG-mediated phagocytic response and also inhibits neutrophil adhesion[1]. | ||||||
| Name | PKI 14-22 amide,myristoylated | ||||||
| CAS | 201422-03-9 | ||||||
| Shortening | Myristoyl-GRTGRRNAI-NH2 | ||||||
| Formula | C53H100N20O12 | ||||||
| Molar Mass | 1209.49 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
PKI 14-22 amide,myristoylated
CAS: 201422-03-9 F: C53H100N20O12 W: 1209.49
PKI 14-22 amide,myristoylated is a potent cAMP-dependent PKA inhibitor. PKI 14-22 amide,myristoylated reduces the IgG-me
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.